Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-031120
Filing Date
2021-08-02
Accepted
2021-08-02 20:34:24
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10848
  Complete submission text file 0000899243-21-031120.txt   12605
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211137531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)